Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2010
09/15/2010CN101831351A Method for extracting ganoderma oil with supercritical carbon dioxide fluid
09/15/2010CN101830957A Process for preparing ginsenosides Rh2 and Rh3 from stems and leaves of pseudoginseng root
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101830879A 5-phenoxybutyldimethylapiolin, preparation method and application
09/15/2010CN101830871A New furan derivative and application thereof
09/15/2010CN101830792A Vitamin K3 derivatives serving as IDO inhibitor
09/15/2010CN101829329A Tooth antiallergic composition
09/15/2010CN101829325A Pharmaceutical composition for treatment of diseases caused by IL-6 production
09/15/2010CN101829318A Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
09/15/2010CN101829312A Medicament for treating rheumatoid arthritis and preparation method thereof
09/15/2010CN101829303A Longevity wine
09/15/2010CN101829277A Oral preparation with immune enhancing function and preparation method thereof
09/15/2010CN101829252A Footbath effervescent tablet for improving sub-health
09/15/2010CN101829246A Transdermal infusion paste preparation for enhancing immunity and preparation method thereof
09/15/2010CN101829228A Method for extracting digitonin
09/15/2010CN101829211A Fish compound traditional Chinese medicinal preparation and preparation method thereof
09/15/2010CN101829210A Method for preparing apple polyphenol
09/15/2010CN101829189A Medicament for treating allergic dermatitis and application thereof in producing skincare products
09/15/2010CN101829162A Pharmaceutical composition for treating allergic rhinitis and preparation method thereof
09/15/2010CN101829145A Elk horn active site and preparation method and application thereof
09/15/2010CN101829143A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
09/15/2010CN101829138A Composition for strengthening immune regulation function in human body and applications thereof
09/15/2010CN101829108A Application of diterpene ginkgolide
09/15/2010CN101829075A Applications of kukoamine A and kukoamine B
09/15/2010CN101829056A Ligustilide fat emulsion and preparation method thereof
09/15/2010CN101829032A Dual-purpose toothpaste composition and preparation method thereof
09/15/2010CN101829025A Bioactive facial mask and preparation method therefore
09/15/2010CN101433160B Method for cultivating medicinal morel and products produced thereby
09/15/2010CN101233884B Method for preparing bead type gynostemma pentaphylla health-care tea
09/15/2010CN101199683B Chinese medicine for treating skin disease and preparing method thereof
09/15/2010CN101180068B Use of polysaccharides extracted from dendrobium in preparing medicine for treating autoimmune disease uveitis
09/15/2010CN101177426B Process for separating extracting spherosinin from gansu whin
09/14/2010US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest
09/14/2010US7795493 tissues, organs and cells for use in xenotransplantation
09/14/2010US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
09/14/2010US7795248 tyrosine kinase inhibitors such as N-[4-(4-amino-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl)phenyl]-N'-phenylurea, used for treating benign or neoplastic proliferative diseases and autoimmune diseases; antitumor agents
09/14/2010US7795206 Peptide that inhibits janus kinase
09/14/2010US7794723 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination
09/14/2010CA2521325C Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
09/14/2010CA2479353C N-substituted benzothiophenesulfonamide derivative
09/14/2010CA2434834C 6-substituted pyrido-pyrimidines
09/14/2010CA2409406C Qs-21 and il-12 as an adjuvant combination
09/14/2010CA2370393C Dna sequence, and recombinant production of a gramineae allergen
09/14/2010CA2347913C Oral administration of adenosine analogs
09/14/2010CA2261666C Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
09/10/2010WO2010101249A1 Method for enhancing function of t cell
09/10/2010WO2010101248A1 Cell proliferation inhibitor and method for screening same
09/10/2010WO2010101164A1 Pyridine derivative
09/10/2010WO2010100515A2 Fractions of wheat germ ferment
09/10/2010WO2010100396A1 Modified omci as a complement inhibitor
09/10/2010WO2010100383A1 Anti-rhesus d monoclonal antibody
09/10/2010WO2010100142A1 Oxazole pyridine derivatives useful as s1p1 receptor agonists
09/10/2010WO2010099613A1 Plant extract compositions for prevention and treatment of influenza
09/10/2010WO2010099612A1 Antibodies and epitopes specific to misfolded prion protein
09/10/2010WO2010070141A3 Microparticles comprising adipose stem cells
09/10/2010WO2010053316A3 New use of sixth immunoglobulin-like domain of vcam-1
09/10/2010WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors
09/10/2010CA2754446A1 Pyridine derivative
09/10/2010CA2754217A1 Methods and systems for treatment and/or diagnosis
09/10/2010CA2754064A1 Plant extract compositions for prevention and treatment of influenza
09/10/2010CA2753700A1 Anti-rhesus d monoclonal antibody
09/10/2010CA2753621A1 Antibodies and epitopes specific to misfolded prion protein
09/10/2010CA2752804A1 Oxazole pyridine derivatives useful as s1p1 receptor agonists
09/09/2010US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/09/2010US20100228007 Mhc-peptide complex binding ligands
09/09/2010US20100227896 Use of vitamin pp compounds
09/09/2010US20100227888 Modulators of cftr
09/09/2010US20100227881 1,7-naphthyridine derivatives as p38 map kinase inhibitors
09/09/2010US20100227860 Disalt inhibitors of il-12 production
09/09/2010US20100227853 Inhibitors of cyclic amp phosphodiesterases
09/09/2010US20100227845 Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
09/09/2010US20100227830 Use of escin
09/09/2010US20100227827 Method of increasing tryptophan and nicotinamide levels in vivo
09/09/2010US20100227818 Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor For The Prevention Of Neutropenia
09/09/2010US20100227814 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes
09/09/2010US20100227800 Triazole derivatives as kinase inhibitors
09/09/2010US20100227797 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
09/09/2010US20100227354 Autoimmune Conditions and NADPH Oxidase Defects
09/09/2010US20100227013 Bacterial extract for respiratory disorders and process for its preparation
09/09/2010US20100227012 Water insoluble helychrisum extract, process for preparing the same and uses thereof
09/09/2010US20100227003 Self-Preserving Compositions
09/09/2010US20100226990 Method of Producing Porous Microparticles
09/09/2010US20100226973 Methods and compositions for liposomal formulation of antigens and uses thereof
09/09/2010US20100226967 Imaging and therapeutic method using progenitor cells
09/09/2010US20100226933 Hypoallergenic proteins
09/09/2010US20100226932 Adjuvant and Vaccine Compositions
09/09/2010US20100226924 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
09/09/2010US20100226923 Antibodies that bind il-4 and/or il-13 and their uses
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/09/2010US20100226912 RECOMBINANT PROTEIN PRODUCTION IN AVIAN EBx® CELLS
09/09/2010US20100226878 Methods of inhibiting photoreceptor apoptosis
09/08/2010EP2226334A2 Immunoregulatory structures from normally occuring proteins
09/08/2010EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii
09/08/2010EP2226323A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/08/2010EP2226315A1 2-aminoquinazoline derivative
09/08/2010EP2225266A1 Novel wheat allergens
09/08/2010EP2225233A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
09/08/2010EP2224936A1 Use of a l. casei strain, for the preparation of a composition for inhibiting mast cell activation
09/08/2010EP2224933A2 Conjugated beta-1,3-linked glucans
09/08/2010EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 1172